Influence of Serum Lipids on Clinically Significant versus Nonclinically Significant Macular Edema. SN-DREAMS Report Number 13

Ophthalmology

Volumn 117, Issue 4, 2010, Pages 766-772

  Raman, Rajiv ^a   Rani, Padmaja Kumari ^a   Kulothungan, Vaitheeswaran ^b   Reddi Rachepalle, Sudhir ^b   Kumaramanickavel, Govindasamy ^b   Sharma, Tarun ^a  

^a SANKARA NETHRALAYA   (India)

^b Department of Preventive Ophthalmology ^*  (India)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALBUMINURIA; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICALLY SIGNIFICANT RETINA MACULA EDEMA; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC MACULAR EDEMA; DYSLIPIDEMIA; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NONCLINICALLY SIGNIFICANT RETINA MACULA EDEMA; PREVALENCE; PRIORITY JOURNAL; RETINA MACULA EDEMA;

BLOOD GLUCOSE; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DIABETIC RETINOPATHY; HUMANS; HYPERCHOLESTEROLEMIA; INDIA; LIPIDS; MACULAR EDEMA; MIDDLE AGED; PREVALENCE; TRIGLYCERIDES;

EID: 77949654258     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.09.005     Document Type: Article

References (29)

1. Strom C., Sander B., Larsen N., et al. Diabetic macular edema assessed with optical coherence tomography and stereo fundus photography. Invest Ophthalmol Vis Sci 43 (2002) 241-245
2. Klein R., Klein B.E., Moss S.E., and Cruickshanks K.J. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XV. The long-term incidence of macular edema. Ophthalmology 102 (1995) 7-16
3. Zander E., Herfurth S., Bohl B., et al. Maculopathy in patients with diabetes mellitus type 1 and type 2: associations with risk factors. Br J Ophthalmol 84 (2000) 871-876
4. Klein R., Davis M.D., Moss S.E., et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: a comparison of retinopathy in younger and older onset diabetic persons. Adv Exp Med Biol 189 (1985) 321-335
5. Chew E.Y., Klein M.L., Ferris III F.L., and ETDRS Research Group. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy: Early Treatment Diabetic Retinopathy Study (ETDRS) report 22. Arch Ophthalmol 114 (1996) 1079-1084
6. Rema M., Srivastava B.K., Anitha B., et al. Association of serum lipids with diabetic retinopathy in urban South Indians-the Chennai Urban Rural Epidemiology Study (CURES) Eye Study 2. Diabet Med 23 (2006) 1029-1036
7. Agarwal S., Raman R., Paul P.G., et al. Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS 1): study design and research methodology. Ophthalmic Epidemiol 12 (2005) 143-153
8. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 26 suppl (2003) S5-S20
9. Klein R., Klein B.E., Magli Y.L., et al. An alternative method of grading diabetic retinopathy. Ophthalmology 93 (1986) 1183-1187
10. Anandaraja S., Narang R., Godeswar R., et al. Low-density lipoprotein cholesterol estimation by a new formula in Indian population. Int J Cardiol 102 (2005) 117-120
11. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 103 (1985) 1796-1806
12. Expert Panel on DetectionEvaluationTreatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
13. Wägner A.M., Pérez A., Sánchez-Quesada J.L., and Ordóñez-Llanos J. Triglyceride-to-HDL cholesterol ratio in the dyslipidemic classification of type 2 diabetes. Diabetes Care 28 (2005) 1798-1800
14. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112 (2005) 2735-2752
15. Frohlich J., and Dobiasova M. Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography. Clin Chem 49 (2003) 1873-1880
16. Dobiasova M. Atherogenic index of plasma [log (triglycerides/HDL-cholesterol)]: theoretical and practical implications. Clin Chem 50 (2004) 1113-1115
17. Raman R., Rani P.K., Rachepalle S.R., et al. Prevalence of diabetic retinopathy in India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study Report 2. Ophthalmology 116 (2009) 311-318
18. Hirvela H., and Laatikainen L. Diabetic retinopathy in people aged 70 years or older: the Oulu Eye Study. Br J Ophthalmol 81 (1997) 214-217
19. Klein R., Klein B.E., Moss S.E., and Linton K.L. The Beaver Dam Eye Study: retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. Ophthalmology 99 (1992) 58-62
20. Delcourt C., Villatte-Cathelineau B., Vauzelle-Kervroedan F., et al., CODIAB-INSERM-ZENECA Pharma Study Group. Visual impairment in type 2 diabetic patients: a multicentre study in France. Acta Ophthalmol Scand 73 (1995) 293-298
21. Mitchell P., Smith W., Wang J.J., and Attebo K. Prevalence of diabetic retinopathy in an older community: the Blue Mountains Eye Study. Ophthalmology 105 (1998) 406-411
22. Klein R., Klein B.E., Moss S.E., and Cruickshanks K.J. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 105 (1998) 1801-1815
23. Savage S., Estacio R.O., Jeffers B., and Schrier R.W. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care 19 (1996) 1243-1248
24. van Leiden H.A., Dekker J.M., Moll A.C., et al. Blood pressure, lipids, and obesity are associated with retinopathy: the Hoorn Study. Diabetes Care 25 (2002) 1320-1325
25. Chowdhury T.A., Hopkins D., Dodson P.M., and Vafidis G.C. The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy?. Eye 16 (2002) 689-693
26. Kennedy A.L., and Lyons T.J. Glycation, oxidation, and lipoxidation in the development of diabetic complications. Metabolism 46 suppl (1997) 14-21
27. Lyons T.J., Jenkins A.J., Zheng D., et al., DCCT/EDIC Research Group. Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. Invest Ophthalmol Vis Sci 45 (2004) 910-918
28. Garvey W.T., Kwon S., Zheng D., et al. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 52 (2003) 453-462
29. Landmesser U., Hornig B., and Drexler H. Endothelial dysfunction in hypercholesterolemia: mechanisms, pathophysiological importance, and therapeutic interventions. Semin Thromb Hemost 26 (2000) 529-537